Oncolytic virotherapy in veterinary medicine: Current status and future prospects for canine patients

21Citations
Citations of this article
40Readers
Mendeley users who have this article in their library.

Abstract

Oncolytic viruses refer to those that are able to eliminate malignancies by direct targeting and lysis of cancer cells, leaving non-cancerous tissues unharmed. Several oncolytic viruses including adenovirus strains, canine distemper virus and vaccinia virus strains have been used for canine cancer therapy in preclinical studies. However, in contrast to human studies, clinical trials with oncolytic viruses for canine cancer patients have not been reported. An 'ideal' virus has yet to be identified. This review is focused on the prospective use of oncolytic viruses in the treatment of canine tumors - a knowledge that will undoubtedly contribute to the development of oncolytic viral agents for canine cancer therapy in the future.

Cite

CITATION STYLE

APA

Patil, S. S., Gentschev, I., Nolte, I., Ogilvie, G., & Szalay, A. A. (2012, January 4). Oncolytic virotherapy in veterinary medicine: Current status and future prospects for canine patients. Journal of Translational Medicine. https://doi.org/10.1186/1479-5876-10-3

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free